165 related articles for article (PubMed ID: 36484014)
1. LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway.
Wang D; Li J; Li W
J Cancer; 2022; 13(14):3584-3592. PubMed ID: 36484014
[TBL] [Abstract][Full Text] [Related]
2. CALD1 facilitates epithelial-mesenchymal transition progression in gastric cancer cells by modulating the PI3K-Akt pathway.
Ma WQ; Miao MC; Ding PA; Tan BB; Liu WB; Guo S; Er LM; Zhang ZD; Zhao Q
World J Gastrointest Oncol; 2024 Mar; 16(3):1029-1045. PubMed ID: 38577446
[TBL] [Abstract][Full Text] [Related]
3. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
4. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
Hu J; Wang M; Yang Y; Xing Y; Li S
Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
[No Abstract] [Full Text] [Related]
6. CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway.
Jiang C; Ma Z; Zhang G; Yang X; Du Q; Wang W
Cancer Manag Res; 2019; 11():10135-10143. PubMed ID: 31819646
[TBL] [Abstract][Full Text] [Related]
7. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
8. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
9. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
10. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
12. m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer.
Lin JX; Lian NZ; Gao YX; Zheng QL; Yang YH; Ma YB; Xiu ZS; Qiu QZ; Wang HG; Zheng CH; Li P; Xie JW; Lu J; Chen QY; Cao LL; Lin M; Wang JB; Huang CM
Cell Death Dis; 2022 May; 13(5):463. PubMed ID: 35568711
[TBL] [Abstract][Full Text] [Related]
13. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
14. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
15. LHPP promotes the intracellular reactive oxygen species accumulation and sensitivity of gastric cancer to cisplatin via JNK and p38 MAPK pathways.
Gao K; Yin N; Shen Z; Li Q; Chen P; Yang K
Histol Histopathol; 2023 Sep; 38(9):1055-1068. PubMed ID: 36546683
[TBL] [Abstract][Full Text] [Related]
16. Phospholysine Phosphohistidine Inorganic Pyrophosphate Phosphatase Regulates Oxidative Stress Response to Affect the Progression of Gastric Cancer.
Song X; Zhang W; Jia T; Ma Y
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38551428
[TBL] [Abstract][Full Text] [Related]
17. High expression of TREM2 promotes EMT via the PI3K/AKT pathway in gastric cancer: bioinformatics analysis and experimental verification.
Li C; Hou X; Yuan S; Zhang Y; Yuan W; Liu X; Li J; Wang Y; Guan Q; Zhou Y
J Cancer; 2021; 12(11):3277-3290. PubMed ID: 33976737
[No Abstract] [Full Text] [Related]
18. MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K/AKT pathway.
Wang H; Min J; Ding Y; Yu Z; Zhou Y; Wang S; Gong A; Xu M
Biol Proced Online; 2024 Jan; 26(1):1. PubMed ID: 38178023
[TBL] [Abstract][Full Text] [Related]
19. LncRNA RP11-93B14.5 promotes gastric cancer cell growth through PI3K/AKT signaling pathway.
Li Q; Zhu Z; Zhang H; Wu X; Yang H; Li X; Li W; Zhao Y; Du F; Chen Y; Shen J; Xiao Z; Chen M; Wang F; Gu L; Sun Y; Lu L; Jia Y; Li M
Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37682457
[TBL] [Abstract][Full Text] [Related]
20. LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway.
Hou B; Li W; Xia P; Zhao F; Liu Z; Zeng Q; Wang S; Chang D
Cell Death Discov; 2021 Oct; 7(1):273. PubMed ID: 34608127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
